Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
05/2005
05/19/2005WO2005044793A2 Nitrogen-containing fused heterocyclic compounds
05/19/2005US20050107368 Inhibitors of cathepsin S
05/19/2005DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases
05/19/2005CA2543707A1 Nitrogen-containing fused heterocyclic compounds
05/19/2005CA2540704A1 Benzoimidazole compounds
05/18/2005EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1616436A 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
05/18/2005CN1201820C Compositions containing benzimidazolones and progestogens
05/17/2005US6894068 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
05/12/2005WO2005042559A2 Capture and release based isotope tagged peptides and methods for using the same
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042496A1 (benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
05/12/2005WO2005042495A1 (benzimidazol-2-yl)-phenyl-phenyl-urea compounds and methods for inhibiting heparanase activity
05/12/2005WO2005001979A3 Fluorinated sulfonamide compounds and polymer electrolyte membranes pepared therefrom for use in electrochemical cells
05/12/2005WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/12/2005US20050101772 Non-metallocenes, method for the production thereof and the use thereof for the polymerisation of olefins
05/12/2005US20050101647 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005CA2543918A1 Benzimidazoles useful as modulators of ion channels
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005CA2539335A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
05/12/2005CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/12/2005CA2528370A1 Capture and release based isotope tagged peptides and methods for using the same
05/11/2005EP1529046A1 Substituted benzimidazole compounds
05/11/2005EP1529035A1 Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents
05/11/2005EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals
05/11/2005EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/11/2005EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia
05/11/2005CN1615300A Benzimidazole derivatives and their use as GNRH antagonists
05/11/2005CN1615299A Xanthine oxidase inhibitors
05/11/2005CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/06/2005WO2005040138A1 Substituted benzylaminoalkylene heterocycles
05/06/2005WO2005040132A1 Dicationic triaryl analogs as anti-protozoan agents
05/06/2005WO2005040131A1 1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/06/2005WO2005040129A2 Ccr3 receptor antagonists
05/06/2005WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005WO2005040093A1 Amino alcohol derivative, medicinal composition containing the same, and use of these
05/06/2005WO2004082638A3 Histone deacetylase inhibitors
05/06/2005CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005CA2543419A1 Ccr3 receptor antagonists
05/06/2005CA2543079A1 Dicationic triaryl analogs as anti-protozoan agents
05/06/2005CA2542695A1 Substituted benzylaminoalkylene heterocycles
05/06/2005CA2541894A1 Amino alcohol derivative, medicinal composition containing the same, and use of these
05/05/2005US20050095533 Nitrogen-containing organic compound, resist composition and patterning process
05/04/2005EP1180519B1 Hydrochloride of fused-heterocycle compound
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1611493A Dibromo glucolycurea sterilizing and disinfecting algaecide preparing method
05/04/2005CN1611492A Bromochloro glucolylurea steribizing and disinfecting algae cide preparing method
05/04/2005CN1611489A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
05/03/2005US6888005 Reacting 3,4-diaminobenzenesulphonic acid with benzaldehyde; for addition to sunscreens
05/03/2005US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors
05/03/2005CA2193994C Process for synthesis of substituted sulphoxides
04/2005
04/28/2005WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors
04/28/2005WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/28/2005US20050090559 Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
04/28/2005US20050090504 Crohn's disease, ulcerative colitis, asthma, hypersensitivity pneumonitis, eosinophilic pneumonias, rhinitis, psoriasis, dermatitis and eczema
04/28/2005US20050090472 Xanthine oxidase inhibitors
04/27/2005EP1524974A2 Transcription factor modulating compounds and methods of use thereof
04/27/2005EP1140856B1 Fluorescent dyes for solid phase and solution phase screening
04/27/2005EP1040098B1 Integrin receptor antagonists
04/26/2005US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders
04/26/2005CA2213124C Benzoyl derivatives
04/21/2005WO2005035526A1 Bicyclic compounds and their therapeutic use
04/21/2005WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent
04/21/2005WO2005035471A1 Ether derivative
04/21/2005WO2005034947A1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/21/2005WO2005011646A3 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents
04/21/2005US20050085488 nitrogen compounds used as preferential inhibitors of cyclic peptide, for prophylaxis of metabolic disorders
04/20/2005EP1524267A1 Substituted benzylaminoalkylene heterocycles
04/20/2005EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
04/20/2005EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors
04/19/2005US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/19/2005US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/14/2005WO2005033065A1 Novel amidine compounds for treating microbial infections
04/14/2005WO2005002503A3 Asymmetric benzimidazoles and related compounds as potassium channel modulators
04/14/2005US20050080141 Amino diols useful in the treatment of alzheimer's disease
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080117 Substituted benzoxazoles as estrogenic agents
04/14/2005US20050080090 Such as 7-(Imidazolo[4,5-b]pyridin-1-yl)-1-(1-methylpyrrolidin-3-yl)naphthalene; for treating depression, anxiety, eating disorders, drug abuse, cluster headache, migraine, pain, and other disorders arising from deficient serotonergic neurotransmission
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005DE10342503A1 Benzyl-Benzimidazolylderivate Benzyl-Benzimidazolylderivate
04/14/2005CA2537791A1 Novel amidine compounds for treating microbial infections
04/13/2005EP1521755A1 Novel diketopyrrolopyrrole pigments
04/13/2005CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them
04/13/2005CN1196485C Compositions for use against parasitic protozoa
04/12/2005US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough
04/12/2005US6878469 Material for transporting electrons and organic electroluminescent display using the same
04/07/2005WO2005030762A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030761A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030733A1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
04/07/2005WO2005030732A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
04/07/2005WO2005009975A3 Benzimidazole derivatives as mek inhibitors
04/07/2005US20050075390 HIV protease inhibitors
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 154